124 related articles for article (PubMed ID: 19499716)
1. [Rifapex, a new antituberculosis agent].
Sokolova GB; Krasnov VA; Reĭkhrud TA; Tsybanev AA
Antibiot Khimioter; 2009; 54(1-2):38-41. PubMed ID: 19499716
[TBL] [Abstract][Full Text] [Related]
2. [Levofloxacin (Tavanic) in complex therapy of tuberculosis].
Sokolova GB; Kunichan AD; Lazareva IaV
Antibiot Khimioter; 2009; 54(1-2):31-7. PubMed ID: 19499715
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and tolerability of a higher rifampin dose versus the standard dose in pulmonary tuberculosis patients.
Ruslami R; Nijland HM; Alisjahbana B; Parwati I; van Crevel R; Aarnoutse RE
Antimicrob Agents Chemother; 2007 Jul; 51(7):2546-51. PubMed ID: 17452486
[TBL] [Abstract][Full Text] [Related]
4. Liposome-based antitubercular drug therapy in a guinea pig model of tuberculosis.
Pandey R; Sharma S; Khuller GK
Int J Antimicrob Agents; 2004 Apr; 23(4):414-5. PubMed ID: 15081096
[No Abstract] [Full Text] [Related]
5. [Reduced mycobacterial resistance to antituberculous drugs in the experiment and clinic: immediate and long-term results].
Belianin II; Shmelev EI
Probl Tuberk Bolezn Legk; 2007; (2):31-8. PubMed ID: 17419333
[TBL] [Abstract][Full Text] [Related]
6. FDA approves rifapentine for the treatment of pulmonary tuberculosis.... Food and Drug Administration.
Roehr B
J Int Assoc Physicians AIDS Care; 1998 Aug; 4(8):19-25. PubMed ID: 11365728
[TBL] [Abstract][Full Text] [Related]
7. Role of isoniazid in once-weekly rifapentine treatment of pulmonary tuberculosis.
Mitchison DA
Am J Respir Crit Care Med; 2003 May; 167(10):1298-9. PubMed ID: 12738593
[No Abstract] [Full Text] [Related]
8. [Therapy of tuberculosis in the adult].
Schrappe M; Wassermann K; Kroegel C
Med Klin (Munich); 1995 Apr; 90(4):229-30. PubMed ID: 7776936
[No Abstract] [Full Text] [Related]
9. Tuberculosis treatment: dangerous regimens?
Rieder HL; Arnadottir T; Trébucq A; Enarson DA
Int J Tuberc Lung Dis; 2001 Jan; 5(1):1-3. PubMed ID: 11263509
[No Abstract] [Full Text] [Related]
10. Evaluation of a non-rifampicin continuation phase (6HE) following thrice-weekly intensive phase for the treatment of new sputum positive pulmonary tuberculosis.
Indian J Tuberc; 2007 Apr; 54(2):84-90. PubMed ID: 17575680
[TBL] [Abstract][Full Text] [Related]
11. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
Zierski M; Bek E
Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
[No Abstract] [Full Text] [Related]
12. [Vesicular eruption in a patient under antituberculosis treatment].
Garrido-Colmenero C; Ruiz-Villaverde R; Martínez-López A; Aneiros-Fernández J
Med Clin (Barc); 2016 Mar; 146(5):e29. PubMed ID: 26602314
[No Abstract] [Full Text] [Related]
13. [Dynamics of the specific process in newly detected patients with destructive pulmonary tuberculosis treated with rifampicin combined with other preparations].
Chukanov VI
Probl Tuberk; 1985; (10):30-4. PubMed ID: 4070201
[No Abstract] [Full Text] [Related]
14. Rifapentine for the treatment of pulmonary tuberculosis.
Munsiff SS; Kambili C; Ahuja SD
Clin Infect Dis; 2006 Dec; 43(11):1468-75. PubMed ID: 17083024
[TBL] [Abstract][Full Text] [Related]
15. A Hong Kong Tuberculosis Treatment Services/Brompton Hospital/British Medical Research Council Investigation.
Tubercle; 1974 Mar; 55(1):1-27. PubMed ID: 4620294
[No Abstract] [Full Text] [Related]
16. Dose selection and pharmacokinetics of rifampin in elephants for the treatment of tuberculosis.
Peloquin CA; Maslow JN; Mikota SK; Forrest A; Dunker F; Isaza R; Peddie LR; Peddie J; Zhu M
J Vet Pharmacol Ther; 2006 Dec; 29(6):581-5. PubMed ID: 17083464
[No Abstract] [Full Text] [Related]
17. Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears.
Diacon AH; Patientia RF; Venter A; van Helden PD; Smith PJ; McIlleron H; Maritz JS; Donald PR
Antimicrob Agents Chemother; 2007 Aug; 51(8):2994-6. PubMed ID: 17517849
[TBL] [Abstract][Full Text] [Related]
18. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
Khodashova ML; Iuditskiĭ MV; Semenova OV
Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
[TBL] [Abstract][Full Text] [Related]
19. [Intermittent chemotherapy of patients with newly detected pulmonary tuberculosis].
Rabukhin AE; Gol'dshteĭn VD; Khodakevich LIa
Probl Tuberk; 1974; (7):14-8. PubMed ID: 4409887
[No Abstract] [Full Text] [Related]
20. [Use of rifampicin in venous perfusion in tuberculosis].
Perna G; Natale F
Clin Ter; 1979 Jul; 90(1):63-73. PubMed ID: 535329
[No Abstract] [Full Text] [Related]
[Next] [New Search]
